Yutaka Horiguchi MD, PhD is currently a Vice Chief Director of Department of Urology, Edogawa Hospital at Tokyo, Japan. He was a research fellow working on Prostate-Specific Membrane Antigen under the direction of Dr. Warren Heston at Memorial Sloan-Kettering Cancer Center and working on immuno-gene therapy for bladder cancer with Dr. William Larchian at The Cleveland Clinic Foundation from 1996 to 99. His clinical subspecialty is urologic oncology and his current work focuses specifically on the serum testosterone levels of prostate cancer patients and the application of artificial intelligence to interpretation of multiparametric MRI of prostate in the process of prostate cancer diagnosis and treatments.
Disclosure information not submitted.